Search Results - Jos G. W. Kosterink

Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease by Bahez Gareb, Antonius T. Otten, Henderik W. Frijlink, Gerard Dijkstra, Jos G. W. Kosterink

Connect to this object online.

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams by Jan-Willem C. Alffenaar, Arianna D. Pranger, Mathieu S. Bolhuis, Jos G. W. Kosterink, Prashant N. Panday

Connect to this object online.

Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review by Nanno Schreuder, Iris de Romijn, Pieter L. Jager, Jos G. W. Kosterink, Eugène P. van Puijenbroek

Connect to this object online.

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process by Bahez Gareb, Silke Posthumus, Max Beugeling, Pauline Koopmans, Daan J. Touw, Gerard Dijkstra, Jos G.W. Kosterink, Henderik W. Frijlink

Connect to this object online.

Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples by Lisanne M. Geers, Dan Cohen, Laura M. Wehkamp, Hans J. van Wattum, Jos G.W. Kosterink, Anton J.M. Loonen, Daan J. Touw

Connect to this object online.

Pharmacometabolomics may be the next stamp in the pharmacogenetic passport by Frank Klont, Marieke A.J. Hof, Fleur B. Nijdam, Daan J. Touw, Stephan J.L. Bakker, Gérard Hopfgartner, Jos G.W. Kosterink, Eelko Hak

Connect to this object online.

Capsules with Ileocolonic-Targeted Release of Vitamin B₂, B₃, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Produ... by Aisha A. Ahmed, Antonius T. Otten, Bahez Gareb, Judith E. Huijmans, Anko C. Eissens, Ateequr Rehman, Gerard Dijkstra, Jos G. W. Kosterink, Henderik W. Frijlink, Reinout C. A. Schellekens

Connect to this object online.